Reorganization of oral anticoagulant (warfarin) treatment follow-up

By Niiranen Samuli   Wartiovaara-Kautto Ulla   Syrjälä Martti   Puustinen Raija   Yli-Hietanen Jari   Mattila Heikki   Kalli Seppo   Lamminen Heikki  

Scandinavian Journal of Primary Health Care, Vol. 24, Iss. 1, 2006-03 ,pp. : 33-37

Informa Healthcare

Access to resources Recommend Favorite

Long-term safety of drug-eluting stents in patients on warfarin treatment

By Annala Antti-Pekka   Karjalainen Pasi P.   Biancari Fausto   Niemelä Matti   Ylitalo Antti   Vikman Saila   Porela Pekka   Airaksinen K. E. Juhani  

Annals of Medicine, Vol. 44, Iss. 3, 2012-05 ,pp. : 271-278

Informa Healthcare

Access to resources Recommend Favorite

Intensity of Long-Term Treatment with Warfarin Is Influenced by Seasonal Variations

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 4, 2009-12 ,pp. : 151-154

Karger

Access to resources Recommend Favorite

New Oral Anticoagulants vs. Warfarin Treatment: No Need for Pharmacogenomics?

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 17-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost of Treating Venous Thromboembolism With Heparin and Warfarin Versus Home Treatment With Rivaroxaban

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 7, 2015-07 ,pp. : 796-802

John Wiley & Sons Inc

Access to resources Recommend Favorite